Anand Burman, Mohit Burman, Aditya Burman & Jimeet Modi join Religare Board
The four leaders join the Board as Non-Executive, Non-Independent Directors
by
Published: Nov 16, 2026 5:32 PM | 3 min read
- Religare Enterprises Limited (REL) has received approval from the Reserve Bank of India to appoint four new Directors, effective November 3, 2026, as part of its governance enhancement and growth strategy.
- The new Directors—Dr. Anand Burman, Mr. Mohit Burman, Mr. Aditya Burman, and Mr. Jimeet Modi—will serve as Non-Executive and Non-Independent Directors for a term of up to five years, bringing diverse expertise in business leadership, healthcare, financial services, and capital markets.
- REL reported a consolidated total income of ₹4,717 crore for the half year ending September 30, 2026, reflecting a 19% year-on-year growth, driven by strong performance in health insurance and financial services.
- The Board's strengthening coincides with REL's focus on consolidating its financial services platform and enhancing operational efficiencies, as it resumes lending activities and continues to grow in various sectors.
Religare Enterprises Limited (REL), a diversified financial services group, has strengthened its Board with the Reserve Bank of India's (RBI) approval for the appointment of four new Directors; Dr. Anand Burman, Mr. Mohit Burman, Mr. Aditya Burman and Mr. Jimeet Modi. The appointments, effective November 3, 2026, mark an important milestone in the Company's governance and leadership journey as it prepares for its next phase of growth.
The appointments follow the Company's earlier proposal to induct the four nominees to its Board in November 2025, subject to the requisite regulatory approvals. All four have been appointed as Additional Directors in the capacity of Non-Executive and Non-Independent Directors for a term of up to five years.
The strengthened Board brings together experience spanning business leadership, entrepreneurship, healthcare, consumer businesses, financial services, capital markets and investment management.
A diverse blend of business and financial services experience
Dr. Anand Burman brings extensive experience in business leadership and the pharmaceutical and consumer healthcare sectors. He holds a PhD in Pharmaceutical Chemistry from the University of Kansas and has been closely associated with the growth and evolution of Dabur, one of India's leading consumer healthcare businesses.
Mr. Mohit Burman, Chairman of Dabur India Limited, brings significant experience in business strategy, financial services, corporate leadership and acquisitions. A fifth-generation member of the Burman family, he has played an instrumental role in expanding the family's business interests across multiple sectors, including consumer products, financial services and insurance.
Mr. Aditya Burman brings entrepreneurial and business-building experience, with interests spanning pharmaceuticals, healthcare and diagnostics. He has served on the Board of Dabur India and has been associated with the growth of Dabur Pharma and Oncquest Laboratories, contributing to business expansion, operational development and international markets.
Mr. Jimeet Modi, Founder and CEO of the SAMCO Group, brings deep expertise in capital markets, equity research, investment analysis, financial technology and wealth management. A Chartered Accountant and CFA charterholder, he has built SAMCO into a diversified financial services and wealth-tech platform encompassing securities broking, asset management, investment research and wealth management.
Operating performance provides the backdrop for the next phase
The Board strengthening comes at a time when Religare is focused on consolidating its diversified financial services platform and accelerating execution across its businesses.
For the half year ended September 30, 2026, REL reported consolidated total income of
₹4,717 crore, compared with ₹3,965 crore in H1 FY26, representing a growth of 19% year-on-year. The performance reflected continued momentum in health insurance and improved operating performance across key financial services businesses.
The Company also operationalised its new corporate office in Mumbai, marking another step in strengthening its institutional and operational infrastructure.
Focus on execution-led growth
The Board strengthening, alongside the resumption of lending at Religare Finvest and continued growth at Care Health Insurance, signals an important phase in REL's evolution.
With a diversified presence across health insurance, lending, housing finance, broking and other financial services, the Company remains focused on strengthening its businesses, improving operational efficiencies and creating sustainable long-term value for stakeholders.
Read more news about People Movement, Internet Advertising, Marketing, Digital Media, PR and Corporate Communication
For more updates, be socially connected with us onInstagram, LinkedIn, Twitter, Facebook, YouTube & Google News
